These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 28780922

  • 1. Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review.
    Ekman-Joelsson BM, Wåhlander H, Synnergren M, Sager M, Mellgren K.
    Cardiol Young; 2017 Nov; 27(9):1823-1831. PubMed ID: 28780922
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F, Kunitake H, Laks H, Odim J.
    Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
    [Abstract] [Full Text] [Related]

  • 6. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E, Özdemir BH, Deniz EE, Tunca MZ, Haberal M.
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [Abstract] [Full Text] [Related]

  • 7. [Post-transplantation lymphoproliferative disorder in childhood].
    Stréhn A, Szőnyi L, Kriván G, Kovács L, Reusz G, Szabó A, Rényi I, Kovács G, Dezsőfi A.
    Orv Hetil; 2014 Feb 23; 155(8):313-8. PubMed ID: 24534879
    [Abstract] [Full Text] [Related]

  • 8. Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level.
    Eshraghian A, Imanieh MH, Dehghani SM, Nikeghbalian S, Shamsaeefar A, Barshans F, Kazemi K, Geramizadeh B, Malek-Hosseini SA.
    World J Gastroenterol; 2017 Feb 21; 23(7):1224-1232. PubMed ID: 28275302
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Post-transplant lymphoproliferative syndrome in the pediatric liver transplant population.
    Molmenti EP, Nagata DE, Roden JS, Squires RH, Molmenti H, Fasola CG, Winick N, Tomlinson G, Lopez MJ, D'Amico L, Dyer HL, Savino AC, Sanchez EQ, Levy MF, Goldstein RM, Andersen JA, Klintmalm GB.
    Am J Transplant; 2001 Nov 21; 1(4):356-9. PubMed ID: 12099380
    [Abstract] [Full Text] [Related]

  • 11. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC, Paya CV, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, Daly RC, McGregor CG.
    J Heart Lung Transplant; 1995 Nov 21; 14(2):214-21. PubMed ID: 7779838
    [Abstract] [Full Text] [Related]

  • 12. Composite risk factors predict survival after transplantation for congenital heart disease.
    Kavarana MN, Savage A, O'Connell R, Rubinstein CS, Flynn-Reeves J, Joshi K, Stroud MR, Ikonomidis JS, Bradley SM.
    J Thorac Cardiovasc Surg; 2013 Oct 21; 146(4):888-93. PubMed ID: 23886031
    [Abstract] [Full Text] [Related]

  • 13. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 21; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 14. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
    Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW.
    Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085
    [Abstract] [Full Text] [Related]

  • 15. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 15; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 16. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
    Katz BZ, Pahl E, Crawford SE, Kostyk MC, Rodgers S, Seshadri R, Proytcheva M, Pophal S.
    Pediatr Transplant; 2007 Feb 15; 11(1):58-65. PubMed ID: 17239124
    [Abstract] [Full Text] [Related]

  • 17. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 15; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 18. Post-transplant lymphoproliferative disease presenting as a mass in the left ventricle in a heart transplant recipient at long-term follow-up.
    Palma JH, Guilhen JC, Gaia DF, Teles A, Teles CA, Branco JN, Buffolo E.
    J Heart Lung Transplant; 2009 Feb 15; 28(2):206-8. PubMed ID: 19201350
    [Abstract] [Full Text] [Related]

  • 19. Imaging findings in children with proliferative disorders following multivisceral transplantation.
    Hryhorczuk AL, Kim HB, Harris MH, Vargas SO, Zurakowski D, Lee EY.
    Pediatr Radiol; 2015 Jul 15; 45(8):1138-45. PubMed ID: 25796382
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.